Protagonist Therapeutics, Inc Uncategorized Contracts & Agreements

18 Contracts & Agreements
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Description of Protagonist Therapeutics, Inc.s Securities Registered Pursuant to Section 12 of the Exchange Act
Protagonist Therapeutics, Inc
Biotechnology
2024
Offer Letter, by and between Protagonist Therapeutics Inc. and Arturo Molina, M.D., Ph.D., dated November 1, 2022
Protagonist Therapeutics, Inc
Biotechnology
2023
Description of Protagonist Therapeutics, Inc.s Securities Registered Pursuant to Section 12 of the Exchange Act
Protagonist Therapeutics, Inc
Biotechnology
2023
Description of Protagonist Therapeutics, Inc.s Securities Registered Pursuant to Section 12 of the Exchange Act
Protagonist Therapeutics, Inc
Biotechnology
2022
Arbitration Resolution Agreement, dated August 4th, 2021, by and among Protagonist Therapeutics, Inc. and Zealand Pharma, A/S
Protagonist Therapeutics, Inc
Biotechnology
2021
Description of Protagonist Therapeutics, Inc.s Securities Registered Pursuant to Section 12 of the Exchange Act
Protagonist Therapeutics, Inc
Biotechnology
2021
Description of Protagonist Therapeutics, Inc.s Securities Registered Pursuant to Section 12 of the Exchange Act
Protagonist Therapeutics, Inc
Biotechnology
2020
Protagonist Therapeutics, Inc. Amended and Restated 2018 Inducement Plan
Protagonist Therapeutics, Inc
Biotechnology
DE
2020
Open Market Sale AgreementSM, dated November 27, 2019, by and between Protagonist Therapeutics, Inc. and Jefferies LLC
Protagonist Therapeutics, Inc
Biotechnology
NY
2019
Offer Letter between Protagonist Therapeutics, Inc. and Donald Kalkofen, dated May 20, 2019
Protagonist Therapeutics, Inc
Biotechnology
2019
ABANDONMENTAGREEMENT
Protagonist Therapeutics, Inc
Biotechnology
2016
AGREEMENT TOASSIGN PATENT APPLICATIONS
Protagonist Therapeutics, Inc
Biotechnology
NY
2016
CONTRACTEXTENSION LETTER OF AGREEMENT hereinafter (Contract Extension) made effective as of June 1st 2013 (Contract Extension Effective Date).
Protagonist Therapeutics, Inc
Biotechnology
2016
INDEMNITY AGREEMENT
Protagonist Therapeutics, Inc
Biotechnology
DE
2016
Additional abbreviations may also be used though not in the above list.
Protagonist Therapeutics, Inc
Biotechnology
2016
ABANDONMENTAGREEMENT
Protagonist Therapeutics, Inc
Biotechnology
2016
AGREEMENT TOASSIGN PATENT APPLICATIONS
Protagonist Therapeutics, Inc
Biotechnology
NY
2016
CONTRACTEXTENSION LETTER OF AGREEMENT hereinafter (Contract Extension) made effective as of June 1st 2013 (Contract Extension Effective Date).
Protagonist Therapeutics, Inc
Biotechnology
2016